Financials data is unavailable for this security.
View more
Year on year Merck Tbk PT had little change in net income (from 179.84bn to 178.24bn) despite revenues that fell -14.51% from 1.12tn to 961.43bn.
| Gross margin | 37.34% |
|---|---|
| Net profit margin | 14.35% |
| Operating margin | 14.88% |
| Return on assets | 14.39% |
|---|---|
| Return on equity | 19.09% |
| Return on investment | 18.11% |
More ▼
Cash flow in IDRView more
In 2023, Merck Tbk PT increased its cash reserves by 18.19%, or 31.01bn. The company earned 203.87bn from its operations for a Cash Flow Margin of 21.21%. In addition the company used 19.90bn on investing activities and also paid 152.96bn in financing cash flows.
| Cash flow per share | 380.05 |
|---|---|
| Price/Cash flow per share | 9.92 |
| Book value per share | 1,561.87 |
|---|---|
| Tangible book value per share | 1,559.52 |
More ▼
Balance sheet in IDRView more
| Current ratio | 3.21 |
|---|---|
| Quick ratio | 1.36 |
| Total debt/total equity | 0.0268 |
|---|---|
| Total debt/total capital | 0.026 |
More ▼
Growth rates in IDR
Year on year, growth in dividends per share remained flat while earnings per share excluding extraordinary items fell by -0.89%. Additionally when measured on a five year annualized basis, dividend per share growth is below the industry average relative to its peers, while earnings per share growth is the highest in its industry.
| Div yield(5 year avg) | 5.84% |
|---|---|
| Div growth rate (5 year) | -34.05% |
| Payout ratio (TTM) | 106.93% |
| EPS growth(5 years) | 36.67 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -9.29 |
More ▼
